InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Dukes Iain D.. Insider active across 3 companies, notably Iovance Biotherapeutics, INC.. Aggregated, 6 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €331k. History available since 23 November 2022. The latest transaction was disclosed on 12 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Dukes Iain D. is a declarant with 6 filings in total. In the recent filings observed, they span from 2022-11-28 to 2025-12-16, with EUR 330890 of buys and EUR 0 of sells, and the most frequent transaction nature is Attribution. They are Chief Executive Officer at Traws Pharma, Inc., Director at Iovance Biotherapeutics, INC., and Director at Theseus Pharmaceuticals, Inc.